Standout Papers
- Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial (2023)
- Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS (2022)
Immediate Impact
1 by Nobel laureates 5 from Science/Nature 60 standout
Citing Papers
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
Harnessing innate immune pathways for therapeutic advancement in cancer
2024 Standout
Works of Ru‐Jing Ren being referenced
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial
2023 Standout
Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ru‐Jing Ren | 541 | 610 | 228 | 250 | 51 | 1.5k | |
| Mahnaz Talebi | 553 | 646 | 234 | 167 | 104 | 1.8k | |
| Shea J. Andrews | 538 | 855 | 279 | 166 | 46 | 1.8k | |
| Eloy Rodríguez‐Rodríguez | 655 | 684 | 281 | 146 | 98 | 1.8k | |
| Grazia Daniela Femminella | 600 | 739 | 144 | 196 | 70 | 2.1k | |
| Paola Piscopo | 394 | 609 | 121 | 267 | 74 | 1.4k | |
| Laura Ghezzi | 709 | 679 | 170 | 216 | 55 | 1.9k | |
| Ning Su | 209 | 366 | 226 | 252 | 55 | 1.2k | |
| Songhua Xiao | 256 | 574 | 87 | 229 | 49 | 1.4k | |
| Jun Xu | 511 | 530 | 224 | 242 | 88 | 2.0k | |
| Hong Shen | 202 | 640 | 185 | 295 | 64 | 1.5k |
All Works
Loading papers...